pyridoxal phosphate has been researched along with 2-deoxy-2,3-dehydro-n-acetylneuraminic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alzari, PM; Botti, H; Brewer, ML; Bryce, RA; Buschiazzo, A; Charlton, MH; Douglas, KT; Edwards, PN; Frasch, AC; Mortenson, PN; Neres, J; Ratier, L | 1 |
| Andrade, P; Campo, VL; Carvalho, I; Dedola, S; Field, RA; Guedes, PM; Hill, L; Nepogodiev, SA; Rejzek, M; Schenkman, S; Sesti-Costa, R; Silva, JS | 1 |
| Alzari, PM; Chen, Z; Crennell, SJ; Frasch, AC; Marcé, P; Resende, R; van den Elsen, JMH; Watts, AG | 1 |
3 other study(ies) available for pyridoxal phosphate and 2-deoxy-2,3-dehydro-n-acetylneuraminic acid
| Article | Year |
|---|---|
Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening.
Topics: Animals; Binding Sites; Catalytic Domain; Chemistry, Pharmaceutical; Crystallization; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Glycoproteins; Inhibitory Concentration 50; Kinetics; Ligands; Models, Chemical; N-Acetylneuraminic Acid; Neuraminidase; Trypanosoma cruzi | 2009 |
'Click chemistry' synthesis of a library of 1,2,3-triazole-substituted galactose derivatives and their evaluation against Trypanosoma cruzi and its cell surface trans-sialidase.
Topics: Animals; Azides; Cell Line; Cell Survival; Chromatography, Thin Layer; Fluorometry; Galactose; Indicators and Reagents; Magnetic Resonance Spectroscopy; Membrane Proteins; Mice; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Neuraminidase; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Spleen; Structure-Activity Relationship; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidase.
Topics: Amination; Chagas Disease; Enzyme Inhibitors; Glycoproteins; Humans; Molecular Docking Simulation; Neuraminidase; Organophosphonates; Trypanocidal Agents; Trypanosoma cruzi | 2018 |